SCHEMBL3721809

SCHEMBL3721809

NC(=O)c1cccc(-c2ccc(OC(F)(F)F)cc2)c1

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 8/20 0.62
▸ BCR P11274 3/20 0.60
▸ KDM4E B2RXH2 1/20 0.60
▸ MAPT P10636 1/20 0.60
▸ MAPK1 P28482 1/20 0.60
▸ AURKA O14965 1/20 0.54
▸ TPX2 Q9ULW0 1/20 0.54
▸ RIPK1 Q13546 1/20 0.53
▸ DYRK1A Q13627 1/20 0.52
▸ F9 P00740 1/20 0.51
▸ PDK2 Q15119 1/20 0.50
▸ DHODH Q02127 1/20 0.50
▸ PLAU P00749 1/20 0.49
▸ PLAT P00750 1/20 0.49
▸ CHEK1 O14757 1/20 0.49
▸ SLC6A2 P23975 1/20 0.48
▸ SLC6A4 P31645 1/20 0.48
▸ ERN1 O75460 1/20 0.48
▸ CHEK2 O96017 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3722117 0.89 DYRK1A (0.62) ABL1BCRKDM4EMAPTMAPK1
SCHEMBL1345700 0.89 HTR2C (0.54) ABL1BCRKDM4EMAPTMAPK1
SCHEMBL28105217 0.88 KDR (0.58) ABL1BCRKDM4EMAPTMAPK1
SCHEMBL3745780 0.86 AURKA (0.67) ABL1MAPTAURKATPX2PDK2
SCHEMBL25602455 0.85 ABL1 (0.60) ABL1BCRMAPTAURKATPX2
SCHEMBL8297933 0.84 ABL1 (0.56) ABL1BCRAURKATPX2CHEK1
SCHEMBL711132 0.82 PARP1 (0.61) ABL1BCRKDM4EMAPTMAPK1
SCHEMBL29448761 0.82 PARP1 (0.61) ABL1BCRKDM4EMAPTMAPK1
SCHEMBL3720366 0.81 DHODH (0.50) ABL1BCRKDM4EMAPTMAPK1
SCHEMBL3727314 0.81 ABL1 (0.54) ABL1BCRKDM4EMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8614201-B2 Heterocyclic amides as modulators of TRPA1 JANSSEN PHARMACEUTICA NV (BE) 2013-12-24 — — US claimed
WO-2010141805-A1 HETEROCYCLIC AMIDES AS MODULATORS OF TRPA1 JANSSEN PHARMACEUTICA NV (BE) 2010-12-09 — — WO claimed
CN-104334529-B Compounds and compositions for inhibiting the activity of ABL1, ABL2, and BCR-ABL1 诺华股份有限公司 2017-03-15 — — CN disclosed
CN-104379574-B For suppressing the heterocyclic carbamate derivatives of the activity of ABL1, ABL2 and BCR ABL1 诺华股份有限公司 2017-03-01 — — CN disclosed
CN-104379574-A Benzamide derivatives for inhibiting the activity of ABL1, ABL 2 and BCR-ABL 1 NOVARTIS AG 2015-02-25 — — CN disclosed
CN-104334529-A Compounds and compositions for inhibiting the activity of ABL1, ABL2, and BCR-ABL1 NOVARTIS AG 2015-02-04 — — CN disclosed
US-8614201-B2 Heterocyclic amides as modulators of TRPA1 JANSSEN PHARMACEUTICA NV (BE) 2013-12-24 — — US disclosed
WO-2010141805-A1 HETEROCYCLIC AMIDES AS MODULATORS OF TRPA1 JANSSEN PHARMACEUTICA NV (BE) 2010-12-09 — — WO disclosed
Send feedback